cerrar
Tagged with Novartis

Czech Stakeholders Unite!
There is frequent dialogue between the pharmaceutical industry, relevant regulatory authorities, and government stakeholders in the Czech Republic,…

Top Pharma Companies in Hungary Ranking
The following chart shows the top pharma companies in Hungary ranked by sales value. Global giant Novartis leads the way with USD 240 million of…

Interview: Manlio Florenzano – Country Head and Managing…
Manlio Florenzano discusses Sandoz's engagement in Italy and the role of generics firms in contributing to a more affordable and sustainable Italian…

Interview: Georg Schroeckenfuchs – Country President,…
Novartis Italy's Georg Schroeckenfuchs discusses the impact of the company's global restructuring on the Italian affiliate, the significance of local…

Interview: Francesco Carugi – Managing Director, Grifols…
Francesco Carugi, Managing Director at Grifols Italy, discusses the company's presence in the plasma, plasma products and plasma diagnostics…

Interview: Fabrice Chouraqui – President Latin America…
PharmaBoardroom spoke to Fabrice Chouraqui, President of Novartis Latin America and Canada at the Financial Times LatAm Healthcare & Life Sciences…

Interview: Peter Catalino – Country President, Novartis Turkey
Novartis country president Peter Catalino discusses the need for Turkey to introduce financial investment incentives to compete more effectively with…

Mehdi Zaghloul – Country President, Novartis Morocco
The country president and general director of Novartis Morocco discusses the impact of the price cuts on the pharma market, the need to change the…

Alexis Serlin – Country President, Novartis Mexico
Novartis strives for “creating solutions for patients that go beyond the pill”. The country head and next president of CANIFARMA discusses how the…

Novartis Korea – Brian Gladsden, President
Brian Gladsden was appointed president of Novartis Korea in January 2014. He relates his previous experience to the market situation in Korea and…

Novartis Malaysia – Michaela Dinboeck, President &…
“Clinical trials are an area where we want to build capabilities, both internally and externally” says Novartis Malaysia's president and managing…

Novartis Malaysia – Michaela Dinboeck, President &…
“Clinical trials are an area where we want to build capabilities, both internally and externally” says Novartis Malaysia's president and managing…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here